SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 12.56 |
Enterprise Value ($M) | -27.13 |
Book Value ($M) | 51.21 |
Book Value / Share | 5.30 |
Price / Book | 0.25 |
NCAV ($M) | 49.33 |
NCAV / Share | 5.11 |
Price / NCAV | 0.25 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.84 |
Return on Assets (ROA) | -0.30 |
Return on Equity (ROE) | -0.42 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.27 |
Current Ratio | 3.27 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 80.67 |
Assets | 82.55 |
Liabilities | 31.33 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 43.95 |
Operating Income | -44.79 |
Net Income | -43.50 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -76.98 |
Cash from Investing | -0.19 |
Cash from Financing | -1.28 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | EcoR1 Capital, LLC | 4.00 | -31.98 | |
13D/A | Sofinnova Capital Vi Fcpr | 2.60 | -90.00 | |
13G/A | Invus Global Management, LLC | 5.90 | ||
13G | Artal International S.C.A. | 5.90 | 463.83 | |
13D | Baker Bros. Advisors Lp | 9.99 | 20.42 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
36,179 | 97,410 | 37.14 | |
18,365 | 94,033 | 19.53 | |
46,418 | 142,379 | 32.60 | |
66,342 | 165,647 | 40.05 | |
(click for more detail) |
Similar Companies | |
---|---|
GYRE – Gyre Therapeutics, Inc. | HCWB – HCW Biologics Inc. |
HEPA – Hepion Pharmaceuticals, Inc. | HOTH – Hoth Therapeutics, Inc. |
HRTX – Heron Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io